The report "Medical Foam Market by Form (Flexible, Rigid, Spray), Material (Polymers, Latex, Metals), Application (Bedding & Cushioning, Medical Packaging, Medical Devices & Components, Prosthetics & Wound Care), and Region - Global Forecast to 2025", is projected to grow from USD 27.7 billion in 2020 and reach USD 37.2 billion by 2025, at a CAGR of 6.1% from 2020 to 2025. The growth of this market can be attributed to the increasing aging population, rise in global health expenditure, and growth of the implantable device sector and consumer shift from traditional to advanced wound care products.
Get PDF brochure of the report: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=176803616
Browse 146 market data Tables and 46 Figures spread through 164 Pages and in-depth TOC on "Medical Foam Market”
The flexible segment to lead the medical foam market during 2020-2025
Flexible foam is the most widely consumed since it is soft, flexible, and resilient. The growth of this foam segment can be attributed to its lower cost compared to rigid and spray foam. Additionally, the substantial consumption of flexible foam in bedding & cushioning applications, packaging of medical devices, and foam dressing in wound care applications, among others, has been driving the market growth. The consumption of flexible foam is higher in such applications due to its properties such as softness, moisture resistance, high impact & mechanical properties.
Polymers segment is expected to lead the medical foam market during the forecast period
Based on material, the basic oxygen furnace segment is expected to be the largest segment of the medical foam industry. The growth of this segment can be attributed to the abundant availability, ease of manufacturing, and low cost. Foamed polymers possess properties such as low weight, heat preservation, sound absorption, biocompatibility, and excellent cushioning. The major types of polymer foam used in medical applications include polyurethane foam, polystyrene foam, polyolefin foam, and others.
Medical packaging is expected to register the highest growth during the forecast period
Medical packaging is expected to register the highest growth in the global medical foam market during the forecast period. The packaging of medical devices, tools, and equipment is crucial to maintain the integrity and hygiene of the product. This includes the packaging of implants, medical equipment & tools, medical devices, and in-vitro diagnostic devices (IVDs). The type of packaging material varies with the application and depends on the functionality of the product; for instance, plastics or metals are used in implants.
Asia Pacific to lead the global medical foam market during the forecast period
Asia Pacific accounted for the largest share of the global medical foam industry in 2020. The market here is anticipated to grow at the highest CAGR between 2020 and 2025. The Asia Pacific region is an emerging and lucrative market for medical foam, owing to the demographic changes, increasing healthcare spending, industrial development, and improving economic conditions. This region constitutes approximately 60% of the world’s population, resulting in the wide-scale use of medical packaging, prosthetics, and medical devices.
Some of the leading manufacturers of medical foam profiled in this report are The Dow Chemical Company (US), SEKISUI CHEMICAL CO., LTD. (Japan), Huntsman Corporation (US), Trelleborg AB (Sweden), BASF SE (Germany), Recticel NV (Belgium), INOAC Corporation (Japan), UFP Technologies, Inc. (US), FXI Holdings, Inc. (US), Armacell International S.A. (Germany), Rogers Corporation (US), Freudenberg Group (Germany), and Molnlycke Health Care (Sweden).
Early buyers will receive 10% free customization on this report.
Don't miss out on business opportunities in Medical Foam Market.
Speak to Our Analyst and gain crucial industry insights that will help your business grow.
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=176803616
About MarketsandMarkets
MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications.
Contact:
Mr. Sanjay Gupta
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
[email protected]
The report "Polyurethane Market by Raw Material (MDI, TDI, Polyols), Product (Coatings, Adhesives & Sealants, Flexible & Rigid Foams, Elastomers), End User (Building & Construction, Automotive & Transportation, Bedding & Furniture) - Global Forecast to 2021", The market is driven by the increasing trend in manufacturing light weight & low carbon emitting vehicles and the improved living standards.
Get PDF brochure of the report: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=151784541 Browse 114 market data tables and 52 figures spread through 183 pages and in-depth TOC on “Polyurethane Market” Bedding & Furniture: Largest End-User of the Polyurethane MarketIn 2015, the bedding & furniture end-use industry accounted for the largest market share in terms of volume, followed by the building and construction, appliances & white goods and automotive & transportation end-users.
The growing urbanization and the improved living standards of the populations, increasing usage of low cost material in the insulation of buildings, and white goods drives the polyurethane market.
Rigid Foam: The Fastest-growing Product Type Segment of the Polyurethane MarketRigid foam products based on polyurethane systems are estimated to grow at the highest CAGR from 2016 to 2021, in terms of volume.
The excellent properties of rigid foam products such as, easy availability, low cost, recyclability, and easy to use, are driving the demand for this segment.
However, India and Thailand are the fastest-growing markets for polyurethane in the region.The following factors are the main driving forces for the polyurethane market in the Asia-Pacific region:The increasing residential building & construction activities are driving the market in the Asia-Pacific region Growing automotive manufacturing activities are expected to drive the demand for polyurethane in the ASEAN countries Covestro AG (Germany), BASF SE (Germany), The Dow Chemical Company (U.S.), Wanhua Chemical Group Co. Ltd. (China), and Huntsman Corporation (U.S.) are the key players in the polyurethane market.
The Business Research Company published its Propylene Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global propylene market.
The report covers the propylene market’s segments- by end-use industry into automotive, construction, packaging, textile, others.View Complete Report: https://www.thebusinessresearchcompany.com/report/propylene-global-market-reportPropylene Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country.
It covers all the regions, key developed countries and major emerging markets.
The major regions included in the report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The propylene market consists of sales of propylene gas and its related services used in various industry verticals such as automotive, construction, and packaging industries.
Asia-Pacific drug safety solutions and pharmacovigilance market is projected to register a substantial CAGR in the forecast period of 2019 to 2026.Drug safety and pharmacovigilance was introduced 170 years ago for detection, assessment, and understanding of the drug action.
The experiment was discovered by Sir James Simpson that chloroform was a powerful anesthetic and for safer use it can be applied in the clinical practices.
The cause of Hannah’s death was studied in order to understand what happened to Hannah as it was difficult to assess the cause of her death and it was assumed that probably lethal arrhythmia or pulmonary aspiration was the main reason leading to such unfavourable situation.
Additionally, in 1961, the U.S. FDA also prohibited false therapeutic indications of drugs.Also, in 1961, European Pharmacovigilance was established after the tragedy of thalidomide which caused an adverse drug reaction named as phocomelia.
In the U.S., ADRs are among the top 10 causes of death, and in the U.K., it was observed that ADRs may cause 5,700 deaths per year.Get More Insights about Asia-Pacific drug safety solutions and pharmacovigilance market, Request Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=asia-pacific-drug-safety-solutions-and-pharmacovigilance-marketSegmentation: Asia-Pacific Drug Safety Solutions and Pharmacovigilance MarketAsia-Pacific drug safety solutions and pharmacovigilance market is segmented into three notable segments which are type, end user and distribution channel.· On the basis of type, the market is segmented into software and services· On the basis of end user, the market is segmented into hospitals, healthcare providers, pharmaceutical & biotechnology industries, KPOs/BPOs, contract research organizations (CROS) and others· On the basis of distribution channel, the market is segmented into direct sales and retail salesKnow more about this report https://www.databridgemarketresearch.com/reports/asia-pacific-drug-safety-solutions-and-pharmacovigilance-marketAsia-Pacific Drug Safety Solutions and Pharmacovigilance Market By Type (Software, Services), End Users (Biotechnology & Pharmaceuticals, Contract Research Organizations (CROS), Hospitals, KPOs/BPOs, Healthcare Providers), Distribution Channel (Direct Sales, Retail Sales), Country (China, Japan, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific) – Industry Trends and Forecast to 2026Competitive Analysis: Asia-Pacific Drug Safety Solutions and Pharmacovigilance MarketSome of the major players operating in Asia-Pacific drug safety solutions and pharmacovigilance market are Pharmaceutical Product Development, LLC, Drug Safety Solutions Limited, C3i, Worldwide Clinical Trials, Bioclinica, United Biosource LLC, Ennov, AB Cube, Covance Inc., Accenture, PRA Health Sciences, Inc., Ergomed, IQVIA, Genpact, Cognizant, Parexel International Corporation, ArisGlobal, ICON plc, Oracle, Syneos Health among others.Get Access Report @ https://www.databridgemarketresearch.com/checkout/buy/singleuser/asia-pacific-drug-safety-solutions-and-pharmacovigilance-marketRecent DevelopmentsIn November 2019, Oracle launched safety-reporting platform in China with dMed Biopharmaceuticals.
The company will provide pharmacovigilance systems to Chinese drug makers and clinical research organisations (CROs).
